Aakaar Medical

Is Aakaar Medical overvalued or undervalued?

As of November 17, 2025, Aakaar Medical is considered overvalued with a PE ratio of 18.23 and an EV to EBITDA ratio of 12.87, despite being lower than some peers like Sun Pharma and Divi's Lab, while its recent stock performance has underperformed the Sensex with returns of -3.24% over the past week and -11.37% over the past month.

As of 17 November 2025, Aakaar Medical's valuation grade has moved from very expensive to expensive. The company is currently considered overvalued based on its financial metrics. The PE ratio stands at 18.23, while the EV to EBITDA ratio is 12.87, and the ROCE is 15.34%. <BR><BR>In comparison to its peers, Aakaar Medical's PE ratio is significantly lower than that of Sun Pharma, which has a PE of 36.69, and Divi's Lab, which is at 69.78. However, it is higher than some peers like Dr. Reddy's Labs, which has a PE of 17.98. The recent performance shows that Aakaar Medical has underperformed the Sensex over the past week and month, with stock returns of -3.24% and -11.37%, respectively, reinforcing the notion of its overvaluation.

Why is Aakaar Medical Technologies Ltd falling/rising?

As of 16-Mar, Aakaar Medical Technologies Ltd's stock price is at 53.50, reflecting a 4.46% decrease and significant underperformance compared to the sector. The stock has declined 27.46% year-to-date and is trading below its moving averages, indicating a bearish trend despite increased investor participation.

As of 16-Mar, Aakaar Medical Technologies Ltd's stock price is falling, currently at 53.50, which reflects a decrease of 2.5 or 4.46%. The stock has underperformed compared to the sector by 3.34% today. Over the past week, the stock has declined by 10.08%, while the benchmark Sensex has only decreased by 2.58%. Year-to-date, Aakaar Medical's stock has dropped significantly by 27.46%, compared to a 10.41% decline in the Sensex.<BR><BR>Additionally, the stock is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. Although there has been a notable increase in investor participation, with a delivery volume rise of 614.29% on March 13, this has not translated into a positive price movement. Overall, the combination of underperformance against the sector, significant declines over multiple periods, and trading below moving averages contributes to the current downward trend in Aakaar Medical Technologies Ltd's stock price.

Which are the latest news on Aakaar Medical?